MedTrace Logo

Urine Exosomes to Identify Biomarkers for LN

NCT04894695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-08-03

No results posted yet for this study

Summary

Urine exosomes will be extracted from patients with lupus nephritis, healthy controls, and patients with systemic lupus erythematosus without lupus nephritis. Transcriptome and/or metabonomics sequencing of exosomes will be performed to screen for molecules in the urine exosomes of patients with lupus nephritis that are significantly different from those of the other groups.

Conditions

Interventions

DIAGNOSTIC_TEST

biomarkers detection in different groups

Biomarkers of urine exosomes in different groups were identified by sequencing technology，then biomarkers were validated using urine samples of different groups

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Liangjing Lu · RenJi Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-02
Primary Completion
2021-08-30
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894695 on ClinicalTrials.gov